CHMP konkluderer, at der ikke er forelagt data, der giver belæg for de i produktresumeerne i Nederlandene, Østrig og Polen påberåbte indikationer urogenitale og gastrointestinale infektioner samt hudinfektioner.
As to where the SPC´s in The Netherlands, Austria and Poland, Methoxasol-T include indications that cover urogenital, gastrointestinal and skin infections, CVMP concludes that no data have been provided supporting these claims.